Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
NCT06476132· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source
Contact: Viktoryiya Livchits
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error